OC
NVS icon

Oakworth Capital’s Novartis NVS Stock Holding History

Oakworth Capital’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Hold
2,335
– – 0.02% 185
2026
Q1 		$357K Sell
2,335
-120
-5% -$18.4K 0.02% 179
2025
Q4 		$338K Buy
2,455
+228
+10% +$29.9K 0.02% 178
2025
Q3 		$286K Sell
2,227
-92
-4% -$11.2K 0.02% 191
2025
Q2 		$281K Hold
2,319
– – 0.02% 174
2025
Q1 		$259K Hold
2,319
– – 0.02% 177
2024
Q4 		$226K Hold
2,319
– – 0.02% 201
2024
Q3 		$267K Sell
2,319
-871
-27% -$98.8K 0.02% 178
2024
Q2 		$340K Sell
3,190
-612
-16% -$61.4K 0.02% 146
2024
Q1 		$368K Sell
3,802
-6
-0.2% -$615 0.03% 142
2023
Q4 		$384K Sell
3,808
-5
-0.1% -$483 0.03% 137
2023
Q3 		$388K Sell
3,813
-71
-2% -$7.21K 0.04% 121
2023
Q2 		$392K Sell
3,884
-50
-1% -$5K 0.03% 124
2023
Q1 		$362K Sell
3,934
-227
-5% -$19.8K 0.03% 121
2022
Q4 		$377K Hold
4,161
– – 0.04% 112
2022
Q3 		$316K Sell
4,161
-60
-1% -$4.97K 0.03% 125
2022
Q2 		$357K Hold
4,221
– – 0.04% 123
2022
Q1 		$370K Sell
4,221
-300
-7% -$26K 0.03% 130
2021
Q4 		$395K Hold
4,521
– – 0.03% 126
2021
Q3 		$370K Hold
4,521
– – 0.04% 126
2021
Q2 		$412K Hold
4,521
– – 0.04% 117
2021
Q1 		$386K Sell
4,521
-23
-0.5% -$2.06K 0.04% 122
2020
Q4 		$429K Sell
4,544
-105
-2% -$9.18K 0.06% 104
2020
Q3 		$404K Buy
4,649
+105
+2% +$9.1K 0.07% 97
2020
Q2 		$397K Sell
4,544
-209
-4% -$18K 0.07% 95
2020
Q1 		$392K Hold
4,753
– – 0.09% 82
2019
Q4 		$449K Sell
4,753
-195
-4% -$17.5K 0.08% 92
2019
Q3 		$430K Sell
4,948
-403
-8% -$36.2K 0.08% 92
2019
Q2 		$489K Sell
5,351
-611
-10% -$51.7K 0.09% 87
2019
Q1 		$514K Hold
5,962
– – 0.11% 86
2018
Q4 		$458K Hold
5,962
– – 0.1% 89
2018
Q3 		$460K Sell
5,962
-673
-10% -$49.8K 0.09% 96
2018
Q2 		$449K Hold
6,635
– – 0.09% 94
2018
Q1 		$456K Hold
6,635
– – 0.11% 86
2017
Q4 		$510K Hold
6,635
– – 0.12% 83
2017
Q3 		$501K Hold
6,635
– – 0.13% 79
2017
Q2 		$496K Hold
6,635
– – 0.14% 80
2017
Q1 		$442K Sell
6,635
-1,431
-18% -$95.4K 0.13% 87
2016
Q4 		$497K Buy
8,066
+357
+5% +$23.2K 0.16% 81
2016
Q3 		$545K Hold
7,709
– – 0.19% 71
2016
Q2 		$549K Buy
7,709
+147
+2% +$10.2K 0.21% 68
2016
Q1 		$491K Hold
7,562
– – 0.2% 71
2015
Q4 		$583K Buy
7,562
+446
+6% +$35.4K 0.24% 63
2015
Q3 		$586K Hold
7,116
– – 0.31% 37
2015
Q2 		$662K Sell
7,116
-1,674
-19% -$154K 0.31% 36
2015
Q1 		$802K Hold
8,790
– – 0.37% 36
2014
Q4 		$730K Buy
8,790
+1,700
+24% +$141K 0.38% 38
2014
Q3 		$571K Hold
7,090
– – 0.34% 35
2014
Q2 		$575K Hold
7,090
– – 0.35% 35
2014
Q1 		$540K Buy
7,090
+3,566
+101% +$260K 0.35% 34
2013
Q4 		$254K Buy
+3,524
New +$245K 0.18% 42

Other funds holding NVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GGI
Godsey & Gibb Inc Richmond, Virginia $1.22B AUM 27.93% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
MIM
Martin Investment Management Palm Beach Gardens, Florida $300M AUM 6.05% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Oakworth Capital's NVS Position: Q2 2026 in Review

Oakworth Capital held its Novartis (NVS) position steady in Q2 2026 at 2,335 shares worth $366K. The position accounts for 0.02% of the portfolio, ranked #185.

Oakworth Capital first reported a position in NVS in Q4 2013 and has held it in 51 quarters since. The position peaked at $802K in Q1 2015. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Oakworth Capital held 2,335 shares of Novartis worth $366K as of Q2 2026.
  • Oakworth Capital left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.02% of Oakworth Capital's portfolio in Q2 2026, its #185 holding.
  • Oakworth Capital first reported a position in Novartis in Q4 2013 and has held it in 51 quarters since.
  • Oakworth Capital's Novartis position peaked at $802K in Q1 2015.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Oakworth Capital's 13F filing for Q2 2026, filed 22 Jul 2026.